Prévisions du marché européen des thérapies du microbiome jusqu’en 2030 – Analyse régionale – par type (thérapeutique et procédure), application (troubles métaboliques et obésité, infection à C. Difficile, maladie inflammatoire de l’intestin et autres) et utilisateur final (hôpitaux et cliniques, centres chirurgicaux ambulatoires , soins à domicile et autres)
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Microbiome Therapeutics Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
5. Europe Microbiome Therapeutics Market - Key Industry Dynamics
5.1 Europe Microbiome Therapeutics Market - Key Industry Dynamics
5.2 Key Market Drivers
5.2.1 Potential of Gut Microbiota in Maintaining Human Health
5.2.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline
5.3 Key Market Restraints
5.3.1 High Cost of Development and Production
5.4 Key Market Opportunities
5.4.1 Increasing R&D to Gain Better Understanding of Human Microbiome
5.5 Key Future Trends
5.5.1 Technological Advancement in Human Microbiome Therapeutics
5.6 Impact of Drivers and Restraints:
6. Microbiome Therapeutics Market - Europe Market Analysis
7. Europe Microbiome Therapeutics Market Analysis - Type
7.1 Therapeutics
7.1.1 Overview
7.1.2 Therapeutics Market, Revenue and Forecast to 2030 (US$ Thousand)
7.2 Procedure
7.2.1 Overview
7.2.2 Procedure Market, Revenue and Forecast to 2030 (US$ Thousand)
8. Europe Microbiome Therapeutics Market Analysis - Application
8.1 Metabolic Disorder and Obesity
8.1.1 Overview
8.1.2 Metabolic Disorder and Obesity Market, Revenue and Forecast to 2030 (US$ Thousand)
8.2 C. Difficile Infection (CDI)
8.2.1 Overview
8.2.2 C. Difficile Infection (CDI) Market, Revenue and Forecast to 2030 (US$ Thousand)
8.3 Inflammatory Bowel Disease
8.3.1 Overview
8.3.2 Inflammatory Bowel Disease Market, Revenue and Forecast to 2030 (US$ Thousand)
8.4 Others
8.4.1 Overview
8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)
9. Europe Microbiome Therapeutics Market Analysis - End User
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics Market, Revenue and Forecast to 2030 (US$ Thousand)
9.2 Ambulatory Surgical Centers
9.2.1 Overview
9.2.2 Ambulatory Surgical Centers Market, Revenue and Forecast to 2030 (US$ Thousand)
9.3 Homecare
9.3.1 Overview
9.3.2 Homecare Market, Revenue and Forecast to 2030 (US$ Thousand)
9.4 Others
9.4.1 Overview
9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)
10. Europe Microbiome Therapeutics Market - Country Analysis
10.1. Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country
10.1.1 Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country
10.1.2 UK
10.1.2.1 UK: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)
10.1.2.2 United Kingdom Europe Microbiome Therapeutics Market Breakdown by Type
10.1.2.2.1 UK: Europe Microbiome Therapeutics Market Breakdown by Therapeutics
10.1.2.3 UK: Europe Microbiome Therapeutics Market Breakdown by Application
10.1.2.4 UK: Europe Microbiome Therapeutics Market Breakdown by End User
10.1.3 Germany
10.1.3.1 Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)
10.1.3.2 Germany: Europe Microbiome Therapeutics Market Breakdown by Type
10.1.3.2.1 Germany: Europe Microbiome Therapeutics Market Breakdown by Therapeutics
10.1.3.3 Germany: Europe Microbiome Therapeutics Market Breakdown by Application
10.1.3.4 Germany: Europe Microbiome Therapeutics Market Breakdown by End User
10.1.4 France
10.1.4.1 France: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)
10.1.4.2 France: Europe Microbiome Therapeutics Market Breakdown by Type
10.1.4.2.1 France: Europe Microbiome Therapeutics Market Breakdown by Therapeutics
10.1.4.3 France: Europe Microbiome Therapeutics Market Breakdown by Application
10.1.4.4 France: Europe Microbiome Therapeutics Market Breakdown by End User
10.1.5 Italy
10.1.5.1 Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)
10.1.5.2 Italy: Europe Microbiome Therapeutics Market Breakdown by Type
10.1.5.2.1 Italy: Europe Microbiome Therapeutics Market Breakdown by Therapeutics
10.1.5.3 Italy: Europe Microbiome Therapeutics Market Breakdown by Application
10.1.5.4 Italy: Europe Microbiome Therapeutics Market Breakdown by End User
10.1.6 Spain
10.1.6.1 Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)
10.1.6.2 Spain: Europe Microbiome Therapeutics Market Breakdown by Type
10.1.6.2.1 Spain: Europe Microbiome Therapeutics Market Breakdown by Therapeutics
10.1.6.3 Spain: Europe Microbiome Therapeutics Market Breakdown by Application
10.1.6.4 Spain: Europe Microbiome Therapeutics Market Breakdown by End User
10.1.7 Rest of Europe
10.1.7.1 Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)
10.1.7.2 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Type
10.1.7.2.1 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Therapeutics
10.1.7.3 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Application
10.1.7.4 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Europe Microbiome Therapeutics Market
12. Company Profiles
12.1 YSOPIA Bioscience SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Ferring Holdings SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Enterome SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Caelus Health BV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Vedanta Biosciences Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Europe Microbiome Therapeutics Market Segmentation
Table 2. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Type
Table 3. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Therapeutics
Table 4. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Application
Table 5. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - End User
Table 6. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Country
Table 7. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type
Table 8. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics
Table 9. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application
Table 10. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User
Table 11. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type
Table 12. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics
Table 13. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application
Table 14. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User
Table 15. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type
Table 16. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics
Table 17. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application
Table 18. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User
Table 19. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type
Table 20. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics
Table 21. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application
Table 22. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User
Table 23. ADULT OBESITY, 2030
Table 24. CHILD OBESITY, 2030
Table 25. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type
Table 26. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics
Table 27. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application
Table 28. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User
Table 29. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type
Table 30. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics
Table 31. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application
Table 32. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User
Table 33. Recent Growth Strategies in Europe Microbiome Therapeutics Market
Table 34. Glossary of Terms, Europe Microbiome Therapeutics Market
List of Figures
Figure 1. Europe Microbiome Therapeutics Market Segmentation, By Country
Figure 2. Europe PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Microbiome Therapeutics Market Revenue (US$ Thousand), 2022 - 2030
Figure 5. Europe Microbiome Therapeutics Market Share (%) - Type, 2022 and 2030
Figure 6. Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand)
Figure 7. Procedure Market Revenue and Forecasts To 2030 (US$ Thousand)
Figure 8. Europe Microbiome Therapeutics Market Share (%) - Application, 2022 and 2030
Figure 9. Metabolic Disorder and Obesity Market Revenue and Forecasts To 2030 (US$ Thousand)
Figure 10. C. Difficile Infection (CDI) Market Revenue and Forecasts To 2030 (US$ Thousand)
Figure 11. Inflammatory Bowel Disease Market Revenue and Forecasts To 2030 (US$ Thousand)
Figure 12. Others Market Revenue and Forecasts To 2030 (US$ Thousand)
Figure 13. Europe Microbiome Therapeutics Market Share (%) - End User, 2022 and 2030
Figure 14. Hospitals and Clinics Market Revenue and Forecasts To 2030 (US$ Thousand)
Figure 15. Ambulatory Surgical Centers Market Revenue and Forecasts To 2030 (US$ Thousand)
Figure 16. Homecare Market Revenue and Forecasts To 2030 (US$ Thousand)
Figure 17. Others Market Revenue and Forecasts To 2030 (US$ Thousand)
Figure 18. Europe Microbiome Therapeutics Market Breakdown by Key Countries - Revenue (2022) (US$ Thousand)
Figure 19. Europe Microbiome Therapeutics Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 20. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)
Figure 21. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)
Figure 22. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)
Figure 23. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)
Figure 24. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)
Figure 25. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)
1. Caelus Health BV
2. Enterome SA
3. Ferring Holdings SA
4. Vedanta Biosciences Inc
5. YSOPIA Bioscience SA